Matthew Doan

Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability

Molecular Cancer Therapeutics · 2020 · Co-first of 11 authors · 28 citations

Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors

Biomaterials · 2020 · 23 citations